← All companies
BridgeBio Pharma, Inc.
BBIO - Company ID 0001743881
Market cap$17.66 B
Rank#665
Filings768
Market capitalization of BridgeBio Pharma, Inc.
As of 2026-07-09, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $17.66 B, making it the #665 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-07-09 | $17.66 B |
| 2026-07-08 | $15.34 B |
| 2026-07-07 | $15.21 B |
| 2026-07-06 | $15.23 B |
| 2026-07-05 | $15.12 B |
| 2026-07-04 | $15.12 B |
| 2026-07-03 | $15.12 B |
| 2026-07-02 | $15.08 B |
| 2026-07-01 | $14.57 B |
| 2026-06-30 | $14.46 B |
| 2026-06-29 | $14.24 B |
| 2026-06-28 | $13.76 B |
Market Cap of similar companies
Frequently asked questions
What is BridgeBio Pharma, Inc.'s market cap?
As of 2026-07-09, BridgeBio Pharma, Inc. (BBIO) has a market capitalization of $17.66 B, making it the #665 most valuable US-listed company.
Where does BridgeBio Pharma, Inc. rank by market cap?
BridgeBio Pharma, Inc. is the #665 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.